These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 8958055)

  • 21. IFN-gamma prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice.
    Donckier V; Abramowicz D; Bruyns C; Florquin S; Vanderhaeghen ML; Amraoui Z; Dubois C; Vandenabeele P; Goldman M
    J Immunol; 1994 Sep; 153(6):2361-8. PubMed ID: 8077653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of murine host-versus-graft disease by anti-CD3 monoclonal antibody.
    Wissing M; Marchant A; Moser M; Flamand V; Leo O; Abramowicz D; Urbain J; Goldman M
    Clin Exp Immunol; 1991 Feb; 83(2):333-7. PubMed ID: 1825190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Ia treatment prevents lupus-like autoimmune syndrome in mice neonatally tolerized to alloantigens.
    Kramar G; Schurmans S; Aguado T; Izui S; Del Giudice G; Lambert PH
    J Autoimmun; 1993 Feb; 6(1):27-37. PubMed ID: 8096138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
    Hori S; Kitagawa S; Iwata H; Ochiai T; Isono K; Hamaoka T; Fujiwara H
    J Exp Med; 1992 Jan; 175(1):99-109. PubMed ID: 1730930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated allogeneic NK cells as suppressors of alloreactive responses.
    Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal tolerance induction in the thymus to MHC-class II-associated antigens. I. Preferential induction of tolerance to Mls antigens and resistance to allo-MHC antigens.
    Hosono M; Kina T; Hosokawa T; Katsura Y
    Cell Immunol; 1986 Nov; 103(1):1-10. PubMed ID: 3542233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of natural regulatory CD4+CD25+ T lymphocytes determines the outcome of tolerance across fully mismatched MHC barrier through linked recognition of self and allogeneic stimuli.
    Fucs R; Jesus JT; Souza Junior PH; Franco L; Verícimo M; Bellio M; Nobrega A
    J Immunol; 2006 Feb; 176(4):2324-9. PubMed ID: 16455989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune syndrome after induction of neonatal tolerance to I-E antigens.
    Gonzalez AL; Conde C; Revilla C; Ramos A; Renedo B; Merino J
    Eur J Immunol; 1993 Sep; 23(9):2353-7. PubMed ID: 8370412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.
    Sugiura K; Kato K; Hashimoto F; Jin T; Amoh Y; Yamamoto Y; Morita H; Okumura K; Ikehara S
    Immunobiology; 1997 Nov; 197(5):460-77. PubMed ID: 9413746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition and response to alloantigens in vivo. II. Priming with accessory cell-depleted donor allogeneic splenocytes: induction of specific unresponsiveness to foreign major histocompatibility complex determinants.
    Ryan JJ; Gress RE; Hathcock KS; Hodes RJ
    J Immunol; 1984 Nov; 133(5):2343-50. PubMed ID: 6207227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L; Bordenave G
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-limited autoimmune disease related to transient donor B cell activation in mice neonatally injected with semi-allogeneic F1 cells.
    de la Hera M; de la Hera A; Ramos A; Buelta L; Alonso JL; Rodriguez-Valverde V; Merino J
    Int Immunol; 1992 Jan; 4(1):67-74. PubMed ID: 1540550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism.
    Martin PJ
    Blood; 1996 Aug; 88(3):962-9. PubMed ID: 8704255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of alternative or concomitant use of perforin- and Fas-dependent pathways in a T cell-mediated negative regulation of Ig production.
    Majlessi L; Bordenave G
    J Immunol; 1999 Apr; 162(8):4391-8. PubMed ID: 10201974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatally tolerant rats actively eliminate donor-specific lymphocytes despite persistent chimerism.
    Cutler AJ; Bell EB
    Eur J Immunol; 1996 Feb; 26(2):320-8. PubMed ID: 8617298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonal analysis of T cell unresponsiveness to alloantigens induced by neonatal injection of F1 spleen cells into parental mice.
    Feng HM; Glasebrook AL; Engers HD; Louis JA
    J Immunol; 1983 Nov; 131(5):2165-9. PubMed ID: 6195253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.